USCB Financial downgraded at Raymond James on loan growth downside risk

As previously reported, Raymond James analyst Michael Rose downgraded USCB Financial (USCB) to Market Perform from Outperform with no price target The firm sees “outsized” downside risk to estimates versus peers given USCB’s high-single to low-double digit loan growth guidance should industry growth slow, the analyst tells investors. M&A is “seemingly on hold in the near term,” which limits potential upside to valuation from a potential sale and the current valuation makes it difficult for a buyer to pay, the analyst added.